Cite
HARVARD Citation
Muendlein, A. et al. (2022). Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. International journal of cardiology. pp. 54-59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muendlein, A. et al. (2022). Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. International journal of cardiology. pp. 54-59. [Online].